Successful treatment of refractory adult onset Still's disease with rituximab.
暂无分享,去创建一个
M. Khanfir | N. Belfeki | F. Said | T. Ben Salem | I. Ben Ghorbel | M. Lamloum | A. Hamzaoui | M. Houman | M. Smiti Khanfir | T. Salem | I. Ghorbel
[1] M. González-Gay,et al. Efficacy of Anakinra in Refractory Adult-Onset Still's Disease , 2015, Medicine.
[2] A. Murasawa,et al. Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission. , 2015, Internal medicine.
[3] J. Ablin,et al. Tocilizumab in Adult-onset Still’s Disease: the Israeli Experience , 2014, The Journal of Rheumatology.
[4] R. Gerli,et al. Successful treatment of refractory adult-onset Still's disease with anti-CD20 monoclonal antibody. , 2009, Clinical and experimental rheumatology.
[5] A. Kontzias,et al. Erratum to: Adult-onset Still’s disease: pathogenesis, clinical manifestations and therapeutic advances , 2012, Drugs.
[6] D. Arkfeld. The potential utility of B cell-directed biologic therapy in autoimmune diseases , 2007, Rheumatology International.
[7] P. Lamprecht,et al. Successful treatment of refractory adult onset Still’s disease with rituximab , 2006, Annals of the rheumatic diseases.
[8] P. Paik,et al. Diagnosis and management of adult onset Still’s disease , 2005, Annals of the rheumatic diseases.
[9] P. van Riel,et al. Refractory adult onset Still’s disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution? , 2005, Annals of the rheumatic diseases.
[10] J. Kadar,et al. Adult-onset Still's disease. , 2004, Best practice & research. Clinical rheumatology.
[11] J. Piette,et al. Proposal for a New Set of Classification Criteria for Adult-Onset Still Disease , 2002, Medicine.
[12] M. Akizuki,et al. Preliminary criteria for classification of adult Still's disease. , 1992, The Journal of rheumatology.